Guangdong Biolight Meditech Co Ltd (300246) fair value: what the stock is really worth
As of Nov 17, 2026: fair value (intrinsic value) of Guangdong Biolight Meditech Co Ltd stock ¥2.64, price ¥12.56, that is 79.0% below the price, quality 46 out of 100. Rating: strongly overvalued. Calculated from audited financials with 2 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Guangdong Biolight Meditech Co Ltd
300246 · SHEFar too expensive (fair value 79% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range ¥5.31 – ¥21.57 · fair‑value band ¥1.85 – ¥3.42 · the ¥12.56 price screens above the ¥2.64 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Guangdong Biolight Meditech Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Guangdong Biolight Meditech Co., Ltd. engages in the research and development, production, sale, and service of medical devices products and solutions in China. It operates in two segments, Life Information and Support, and Kidney Disease.
Show moreShow less
The company offers emergency and critical care monitor, subcritical care monitor, general ward monitor, outpatient monitor, neonatal monitor, infusion pump, electrocardiograph, maternal and fetal monitor, defibrillator, multifunctional suspension device, internet of things, and central station; hemodiafiltration equipment, peritoneal dialysis equipment, liquid supply system, and hemodialysis water equipment; and finger clip oximeter, sphygmomanometer, fetal heart rate monitor, body temperature monitoring system, and home medical mall, as well as hemoperfusion devices, high throughput and low flu hemodialyzer, hemodialysis concentrate, dry powder, citric acid disinfectant, tube/puncture needle, dialysate filter, and dialysis fluid filter.
It offers its products under JUNKANG MEDICAL, BIOLIGHT HEALTHCARE, TRUSTRONG, BR Medical Service, SHENBA, HUA VUE MEDICAL, BOAO TIANSHENG, and other brand names. The company serves medical institutions through direct sales channel. It also exports its products.
The company was founded in 1993 and is headquartered in Zhuhai, China.
Stock analysis
Guangdong Biolight Meditech Co Ltd (300246) currently trades at ¥12.56, while our model-based Fair Value estimate is ¥2.64, 79% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 2 models at a data quality of 90/100, which puts the data coverage at low.
Scenario range: ¥1.85 (bear) to ¥3.42 (bull), the price of ¥12.56 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 46/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Guangdong Biolight Meditech Co Ltd reported revenue of 1.1B CNY in FY2025 versus 1.1B CNY in FY2021, a compound +0.1%/yr. Reported net income was −69.4M CNY in FY2025.
Key figures
Market cap 3.3B CNY (≈ $499M) Small · P/S ratio 3.18 · EPS (TTM) ¥−0.4400 · Dividend yield 0.4% · Net margin −6.3% · Return on equity −9.7% · Return on assets (EBIT) 0.2% (5-year average) · Revenue (TTM) 1.1B CNY.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 14 out of 100 (low confidence).
What moves the price
The share trades about 42% below its 52-week high and 60% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −16% fair-value upside, at −79%, 300246 screens richer than that median.
Fair Value models
All 2 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
300246 screens overvalued: fair value 79% below the price. Compare with Abbott Laboratories, →
Compare Guangdong Biolight Meditech Co Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 401 stocks
Valuation Multiplesvs Medical Devices median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/B ratio by industry
- Net margin by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Chinese Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| DexCom, Inc DXCM | $81.61 | $91.66 | +12% | vs 300246 |
| Boston Scientific Corporation BSX | $43.69 | $48.77 | +12% | vs 300246 |
| Stryker Corporation SYK | $310.72 | $340.60 | +10% | vs 300246 |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥185.38 | ¥197.34 | +6% | vs 300246 |
| GE HealthCare Technologies Inc GEHC | $82.96 | $69.92 | −16% | vs 300246 |
| Siemens Healthineers AG SHL | €43.30 | €34.51 | −20% | vs 300246 |
| Edwards Lifesciences Corporation EW | $107.11 | $81.94 | −24% | vs 300246 |
| Medtronic plc MDT | $102.88 | $74.89 | −27% | vs 300246 |
| Abbott Laboratories, ABT | $107.45 | $75.28 | −30% | vs 300246 |
| Koninklijke Philips N.V PHIA | €27.16 | €15.23 | −44% | vs 300246 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Guangdong Biolight Meditech Co Ltd (300246) overvalued or undervalued?
What is the fair value of 300246?
What is the quality score of 300246?
What is the price target for Guangdong Biolight Meditech Co Ltd (300246)?
What is the Guangdong Biolight Meditech Co Ltd stock forecast for 2026?
What is the revenue of Guangdong Biolight Meditech Co Ltd (300246)?
Does Guangdong Biolight Meditech Co Ltd pay a dividend?
How much is the dividend of Guangdong Biolight Meditech Co Ltd (300246) and when is the ex-dividend date?
What is the intrinsic value of Guangdong Biolight Meditech Co Ltd (300246)?
Is Guangdong Biolight Meditech Co Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 300246?
How much is Guangdong Biolight Meditech Co Ltd worth?
What do the bullish and bearish scenarios say about 300246?
What is the PEG ratio of 300246?
How solid is the balance sheet of Guangdong Biolight Meditech Co Ltd (300246)?
How far is 300246 from its 52-week high?
Which stocks are comparable to Guangdong Biolight Meditech Co Ltd?
Is Guangdong Biolight Meditech Co Ltd stock attractive at the current price?
How is the fair value of 300246 calculated?
Is it still worth investing in stocks now?
What is the share price of Guangdong Biolight Meditech Co Ltd (300246)?
What should I pay attention to with Guangdong Biolight Meditech Co Ltd right now?
Key figures of Guangdong Biolight Meditech Co Ltd
How large is the market capitalisation of Guangdong Biolight Meditech Co Ltd (300246)?
What is the P/S ratio of Guangdong Biolight Meditech Co Ltd (300246)?
What are the earnings per share of Guangdong Biolight Meditech Co Ltd (300246)?
What is the dividend yield of Guangdong Biolight Meditech Co Ltd (300246)?
What is the net margin of Guangdong Biolight Meditech Co Ltd (300246)?
What is the return on equity of Guangdong Biolight Meditech Co Ltd (300246)?
What is the EBIT return on assets of Guangdong Biolight Meditech Co Ltd (300246)?
How fast is revenue growing at Guangdong Biolight Meditech Co Ltd (300246)?
How fast are earnings growing at Guangdong Biolight Meditech Co Ltd (300246)?
How much free cash flow does Guangdong Biolight Meditech Co Ltd (300246) generate?
How much net debt does Guangdong Biolight Meditech Co Ltd (300246) carry?
Watch Guangdong Biolight Meditech Co Ltd in the live analysis
One click puts Guangdong Biolight Meditech Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.